LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Advancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testing
In a recent webinar, Dr. Lena Smirnova explained how brain microphysiological systems are transforming in vitro neurotoxicity testing and disease modeling. NewsMedical compiled the key highlights in ...
Low-dose dissolution frequently demands reduced media volumes to keep early time-point concentrations above LOQ, and regulators may expect evaluation of higher-sensitivity analytics before lowering ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results